SOSAFE
4.6.2024 09:01:35 CEST | Business Wire | Press release
SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed seasoned HR executive Laura Ryan as Chief People Officer to support the organisation as they continue to scale operations internationally in the face of rising global cyber security threats.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604322632/en/
Laura Ryan appointed as new Chief People Officer at largest security awareness and human risk management platform SoSafe. (Photo: Business Wire)
Laura will lead SoSafe’s people function, overseeing the development of a best-in-class team to help deliver the company’s next chapter of strategic growth. She will manage human resources, people and talent, workspace and community, and operations, acting as an engine to accelerate the company’s mission and long-term vision to strengthen digital self-defence.
With over 20 years of hands-on experience in the technology and financial services industries, Laura has actively supported the evolution of HR functions. Prior to joining SoSafe, she worked almost nine years at Dropbox, most recently as Vice President Global HR Business Partnering. Prior to this, Laura spent over five years at Google and over seven years in Financial Services in a number of HR roles, honing her HR craft.
Laura Ryan, incoming Chief People Officer at SoSafe: “Throughout my career I've been passionate about scaling organisations, helping companies achieve this by fostering innovation and creating workplaces that inspire people to do their best work. SoSafe is working in an extremely interesting market with very strong dynamics: Cybercrime is the biggest threat to organisations and SoSafe delivers a human-centric solution based on psychology. This gives the company and the team a very strong purpose and I am very excited to contribute to their mission to empower people facing digital threats.”
SoSafe is currently leading the category evolution from security awareness and training to human risk management through product innovation, accelerating its sustainable growth. Since the beginning of 2022, they have grown from 180 employees in Cologne, Germany, to 500 employees across nine locations in Europe with around 100 open positions, recently adding two additional office hubs in Dublin, Ireland, and Chemnitz, Germany.
Dr Niklas Hellemann, CEO of SoSafe: "One of the pillars of our success is the excellence of our people - we are proud to have an outstanding team to drive our ambitious plans. Laura brings a wealth of experience in fast-paced, multi-cultural organisations and has proven her ability to build and lead people divisions in high growth technology companies. I am very excited to have her join our management team and look forward to working with her to drive further growth for the business.”
Laura's appointment follows a series of senior hires to strengthen the company's expertise.:
- Megan Brown joins as Vice President of Global Partnerships, bringing more than 15 years of sales experience at LogicGate, Checkster and CareerBuilder to lead SoSafe's plans to expand its channel sales through international partnerships.
- Gina Dragulin joins as Vice President of Product Marketing to ensure that SoSafe's product innovations are brought to life and their customers get highest value. Prior to joining SoSafe, she worked for Miro, Microsoft and other tech companies while leading various marketing functions.
- Thomas Owen joins as Chief Information Security Officer, bringing with him a wealth of experience in the security industry from companies such as Grafana Labs, iloomi and Snyk.
About SoSafe
SoSafe, founded by a team of behavioural scientists and technology experts, is the largest security awareness and human risk management vendor based in Europe. SoSafe is empowering over 4700 customers worldwide to effectively mitigate cyber risk. With a unique human-centric approach grounded in behavioural science, SoSafe enhances secure behaviour across organizations, making it intuitive and second nature. The platform is designed to strengthen digital self-defence by creating robust security cultures that actively involve employees in mitigating human risks. By leveraging psychology and advanced technology and AI, it enables security professionals to effectively identify, prioritize, manage, and ultimately reduce their human risk. The SoSafe team now consists of more than 500 employees in nice locations: Cologne (headquarters), Amsterdam, Berlin, Chemnitz, Dublin, London, Paris, Lisbon, and Munich.
Website: www.sosafe-awareness.com/
LinkedIn: www.linkedin.com/company/sosafe-cyber-security/mycompany/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240604322632/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
